New Thermostatic Laboratory Chillers

Laboratory products

New Thermostatic Laboratory Chillers

22 Mar, 2011

Published over 15 years ago. See the latest and most current information on Laboratory products.

Thermo Fisher Scientific, Inc has launched the new Thermo Scientific Polar Series thermostatic laboratory chillers, the Accel 250 and Accel 500. The Polar Series has a temperature range from -10 to 80°C, allowing users to select the optimal set-point for each application. Thermostatic technology enables fast temperature ramping, and this delivers immediate heating and cooling for an extremely efficient workflow. Furthermore, the energy-saving mode in the Series makes it an environmentally friendly option for any laboratory requiring precise temperature control. The Polar Series is ideal for an expansive range of applications, including chemical reaction control, separations, spectroscopy and surface science.

These easy-to-use laboratory chillers are programmable via an intuitive user interface, making it simple to set required temperature parameters. A compact footprint and minimal noise enable convenient in-lab placement, increasing laboratory efficiency. An internal reservoir and pump and cooling capacity options ensure extremely accurate temperature performance. The integrated fill port, drain and site tube design facilitates quick and easy operation. This range of CE- and CSA-compliant chillers has an intuitive plug and play design, eliminating any lengthy installation processes.

ILM Guide 2026/27

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Do we need to widen our sampling sources for PFAS contamination?
Explore more Arrow
Pollution Solutions Online
Next-generation reverse osmosis membranes for more efficient and cost-effective seawater desalination
Explore more Arrow
Petro Online
Three generations of innovation. One powerful new platform
Explore more Arrow
Chromatography Today
Wiley expands forensic drug database for faster identification of designer drugs
Explore more Arrow